BWX Technologies (BWXT) Announces $21B 10-Year Environmental Management Contract for DOE
Get Alerts BWXT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.5%
EPS Growth %: +2.9%
Join SI Premium – FREE
(Updated - October 28, 2021 1:18 PM EDT)
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Savannah River Site (SRS) in South Carolina.
The DOE announced the award of the Savannah River Site Integrated Mission Completion Contract to Savannah River Mission Completion, LLC (SRMC), which is a joint venture led by a BWXT subsidiary and includes subsidiaries of Amentum and Fluor. The team includes two pre-selected small businesses, DBD and Wesworks (a woman-owned business), who provide specialized modeling and project controls expertise, respectively.
“This is a strategically important win for BWXT and demonstrates our ability to address some of the most complex environmental challenges in the nation,” said Ken Camplin, president of BWXT’s Nuclear Services Group. “We intend to work with our SRMC teammates, our DOE customer, the regulatory authorities and the community in making a significant impact on waste management at SRS for many years to come.”
The scope of work for the contract includes liquid waste stabilization/disposition and potentially nuclear materials management and stabilization, among other requirements. SRS is a 310-square-mile site that encompasses parts of Aiken, Barnwell and Allendale counties in South Carolina and is bordered on the west by the Savannah River and Georgia.
More information is available from the DOE’s Office of Environmental Management here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Upgrades BWX Technologies (BWXT) to Buy
- Gates Industrial launches three new bicycle belt drive sprocket families
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Create E-mail Alert Related Categories
Corporate News, Hot Corp. NewsRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share